Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Go back to Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma| (NASDAQ: NTRA) | Delayed: 395.56 -5.09 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $400.65 | 52 Week High | $13.80 | |||
| Open | $393.02 | 52 Week Low | $6.52 | |||
| Day High | $401.09 | P/E | N/A | |||
| Day Low | $383.45 | EPS | $0.00 | |||
| Volume | 2,816,398 | |||||



